Skip to main content
PFE
NYSE Life Sciences

Pfizer Commits $650M Upfront in $10.5B Oncology Collaboration with Innovent for 12 New Medicines

Tom Rudovsky · Reported by PR Newswire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$26.13
Mkt Cap
$148.983B
52W Low
$23.06
52W High
$28.745
52W Position info
13% above low
Off High info
9.1% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

PFE is trading near its 52-week low of $23.06 (13% above the low).

Summary

Pfizer has entered a global strategic collaboration with Innovent Biologics to develop 12 early-stage oncology medicines, including novel antibody-drug conjugates and multi-specific antibodies. Pfizer will make a $650 million upfront payment to Innovent and is eligible for up to $9.85 billion in development, regulatory, and commercial milestone payments, totaling up to $10.5 billion. This significant partnership strengthens Pfizer's oncology pipeline by leveraging Innovent's early-stage innovation and Pfizer's global development and commercialization capabilities. This follows a period of positive news for Pfizer, including strong Q1 results and an acquisition of obesity assets, further bolstering its long-term growth prospects in a critical therapeutic area.

At the time of this announcement, PFE was trading at $26.13 on NYSE in the Life Sciences sector, with a market capitalization of approximately $149B. The 52-week trading range was $23.06 to $28.75. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

PFE - Latest Insights

PFE
Nov 03, 2026, 8:19 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $30.66
Real-time Price: $29.90 info
Change: -$0.7594 (-2%) info
Market Cap: $170.312B info
PFE
Nov 03, 2026, 8:07 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $30.62
Real-time Price: $29.90 info
Change: -$0.7248 (-2%) info
Market Cap: $170.312B info
PFE
Nov 03, 2026, 6:55 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $30.73
Real-time Price: $29.90 info
Change: -$0.830 (-3%) info
Market Cap: $170.312B info
PFE
Nov 03, 2026, 6:45 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $30.98
Real-time Price: $29.90 info
Change: -$1.08 (-3%) info
Market Cap: $170.312B info
PFE
Oct 27, 2026, 6:45 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $29.77
Real-time Price: $29.90 info
Change: +$0.130 (+0.44%) info
Market Cap: $170.312B info